Application of anti-Xa assay in monitoring unfractionated heparin therapy in contemporary antithrombotic management

Keyphrases

• Activated Partial Thromboplastin Time (aPTT) 20%
• Acute Management 20%
• Acute Treatment 20%
• Anti-Xa Activity 40%
• Anti-Xa Assay 100%
• Anticoagulant Property 20%
• Anticoagulation Management 20%
• Antithrombotic Management 100%
• Area Cover 20%
• Clinical Outcomes 20%
• Disease Interaction 20%
• Drug Interactions 20%
• Evidence-based 20%
• Expert Opinion 20%
• Frequent Monitoring 20%
• Hematological Variables 20%
• Hemostasis 20%
• Heparin Therapy 100%
• In Vivo Analysis 20%
• Preventive Treatment 20%
• PubMed 20%
• Significant Disease 20%
• Thrombosis 20%
• Thrombosis Treatment 20%
• Unfractionated Heparin 100%

Medicine and Dentistry

• Anticoagulation 25%
• Antithrombotic 100%
• Blood Stasis 25%
• Diseases 25%
• Drug Interaction 25%
• Heparin 100%
• Heparinization 100%
• In Vitro 25%
• Partial Thromboplastin Time 25%
• Thrombosis 50%

Pharmacology, Toxicology and Pharmaceutical Science

• Anticoagulant Agent 100%
• Blood Stasis 25%
• Disease 25%
• Drug Interaction 25%
• Heparin 100%
• Thromboplastin 25%
• Thrombosis 50%